capital · May 15, 2026
Google-Backed Isomorphic Labs Raises $2.1 Billion for AI-Driven Drug Efforts
Share the canonical public link.
Isomorphic Labs raised $2.1 billion in funding on May 12, 2026, led by Thrive Capital. The round includes Google Ventures, Alphabet, MGX, Temasek, and CapitalG as participants. Proceeds fund expansion of AI models for drug discovery across modalities and partnerships. Agreements with Novartis, Eli Lilly, and Johnson & Johnson incorporate IsoDDE into joint programs with milestone structures. Demis Hassabis founded the company in 2021, building on DeepMind technology for a London base.
Failed after 3 attempts. Last error: Service unavailable